SARS-CoV-2 main protease — Drug Target
All drugs that target SARS-CoV-2 main protease — marketed and clinical-stage. Includes 2 drug classes acting on this target.
Drug classes
SARS-CoV-2 main protease inhibitor · Protease inhibitor
Marketed (3)
- Ximingting Tablet · Peking Union Medical College Hospital · SARS-CoV-2 main protease inhibitor · Infectious Disease
Ximingting Tablet is a small molecule that inhibits the SARS-CoV-2 main protease. - (E) BQ-V14 · National Taiwan University Hospital · SARS-CoV-2 main protease inhibitor · Infectious Diseases
BQ-V14 is a small molecule that targets the SARS-CoV-2 main protease. - Pf-07817883 · Pfizer · Protease inhibitor · Infectious Disease
Phase 3 pipeline (7)
- wIPV · Beijing Minhai Biotechnology Co., Ltd · SARS-CoV-2 main protease inhibitor · Infectious Diseases
WIPV is a small molecule targeting the SARS-CoV-2 main protease. - AD-203 · Addpharma Inc. · SARS-CoV-2 main protease inhibitor · Infectious Disease
AD-203 is a small molecule that targets the SARS-CoV-2 main protease. - WPV01 · Westlake Pharmaceuticals (Hangzhou) Co., Ltd. · SARS-CoV-2 main protease inhibitor · Infectious Diseases
WPV01 is a small molecule drug that targets the SARS-CoV-2 main protease. - NUCS · IRCCS San Raffaele · SARS-CoV-2 main protease inhibitor · Infectious Diseases
NUCS is a small molecule that targets the SARS-CoV-2 main protease. - AG2001 · Ahn-Gook Pharmaceuticals Co.,Ltd · SARS-CoV-2 main protease inhibitor · Infectious Diseases
AG2001 is a small molecule that targets the SARS-CoV-2 main protease. - TTYP01 tablets · Shanghai Auzone Biological Technology Co., Ltd. · SARS-CoV-2 main protease inhibitor · Infectious Diseases
TTYP01 tablets are a small molecule drug that targets the SARS-CoV-2 main protease. - XC221 · RSV Therapeutics LLC · SARS-CoV-2 main protease inhibitor · Infectious Disease
XC221 is a small molecule that inhibits the activity of the SARS-CoV-2 main protease.
Phase 2 pipeline (6)
- ETH47 · Ethris GmbH · SARS-CoV-2 main protease inhibitor · Infectious Diseases
ETH47 is a small molecule that targets the SARS-CoV-2 main protease. - GRT-C901 · Seattle Project Corporation · SARS-CoV-2 main protease inhibitor · Infectious Diseases
GRT-C901 is a small molecule that targets the SARS-CoV-2 main protease. - CDI-31244 · Cocrystal Pharma, Inc. · SARS-CoV-2 main protease inhibitor · Infectious Diseases
CDI-31244 is a small molecule inhibitor targeting the SARS-CoV-2 main protease. - BTA798 · Biota Scientific Management Pty Ltd · SARS-CoV-2 main protease inhibitor · Infectious Diseases
BTA798 is a small molecule inhibitor of the SARS-CoV-2 main protease. - CC-42344 · Cocrystal Pharma, Inc. · SARS-CoV-2 main protease inhibitor · Infectious Disease
CC-42344 is a small molecule inhibitor of the SARS-CoV-2 main protease. - Flotufolastat F18 · Icahn School of Medicine at Mount Sinai · SARS-CoV-2 main protease inhibitor · Infectious Disease
Flotufolastat F18 is a small molecule that targets the SARS-CoV-2 main protease.